Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? Neural Regeneration Research . 2021, (7): 1397 -1398 .  DOI: 10.4103/1673-5374.300986